Latest Manufacturing News

AdAlta has secured a formal US FDA pre-IND meeting for EW-001, moving its mesothelioma CAR-T therapy into a critical regulatory review. The November meeting will test the company’s Australian manufacturing, remaining studies and proposed Phase 1 trial before the more expensive stages of development begin.

Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.

Metals Australia has reported a 50 Mt graphite resource, a maiden 21.51 Mt probable ore reserve and strong study-stage economics for its Quebec project. The opportunity is substantial, but the company ended the year with just AUD 3.73 million in cash and no mining revenue.

Rua Bioscience delivered a sharp rise in customer revenue and secured a UK agreement expected to generate NZ$10 million over two years. But PwC disclaimed an audit opinion, warning the company may not have enough cash without another capital raise.

Biome Australia Limited (ASX:BIO) delivered its second consecutive profitable year in FY26, with revenue rising 30% to $23.9 million and operating cash flow turning positive. But the headline $3.6 million profit includes a $2.4 million deferred tax benefit, leaving FY27 execution as the real test of the company’s growth plan.

AML3D will contribute about A$530,000 to a three-year, A$3.89 million research project aimed at qualifying its Wire-Arc Additive Manufacturing technology for aerospace tooling. The project carries no immediate revenue, but could open the door to future production contracts if qualification succeeds.

Microba shareholders would own about 67% of an enlarged Genetic Signatures under a proposed all-scrip merger valued at approximately A$51 million. The deal combines roughly A$29.6 million of FY2026 revenue and identifies up to A$3 million in potential annual cost synergies, but remains subject to a long list of approvals.

Kali Metals has secured up to $700,000 in exploration funding from Japan’s JX Advanced Metals for its 1,413 square kilometre Southern Lachlan project. The agreement creates a pathway to a potential farm-in or joint venture, but no formal deal has yet been agreed.

FFI Holdings lifted underlying pre-tax profit 6.8% to $4.62 million in FY2026, while food manufacturing delivered stronger earnings and operating cash flow rebounded sharply. The ASX-listed group now plans a $5.1 million factory and warehouse development in Cockburn, funded from existing resources.

Nanoveu has received the first packaged engineering samples of its 16nm ECS-DoT edge AI chip from TSMC, moving the program from design files to physical silicon. The next test is whether the added memory, radio and accelerators deliver the power and performance promised on paper.

Korvest has entered FY27 with record work on hand after completing a new 3,500 square metre Kilburn factory, even as FY26 profit and operating cash flow declined. The ASX-listed manufacturer maintained its 40-cent fully franked final dividend and plans another $4 million capacity investment.

Advanced Engineered Materials is targeting a sharp increase in high-purity alumina sales while laying the groundwork for a possible doubling of Cap-Chat capacity to 6,000 tonnes per annum. The opportunity is substantial, but much of the customer pipeline remains uncontracted and the expansion still depends on feasibility work, financing and a final investment decision.